Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Atellica CH Diazo Total Bilirubin (D_TBil)

K-Number: K251998 · 2026-02-27

Decision Date2026-02-27
Product CodeCIG
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Atellica CH Diazo Total Bilirubin (D_TBil) is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2026-02-27 under approval number K251998. The device is classified under product code CIG. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Atellica CH Diazo Total Bilirubin (D_TBil)?

Atellica CH Diazo Total Bilirubin (D_TBil) is a medical device that received FDA 510(k) clearance on 2026-02-27. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K251998.

When was Atellica CH Diazo Total Bilirubin (D_TBil) approved by the FDA?

Atellica CH Diazo Total Bilirubin (D_TBil) received FDA 510(k) clearance on 2026-02-27, under approval number K251998.

What company makes Atellica CH Diazo Total Bilirubin (D_TBil)?

Atellica CH Diazo Total Bilirubin (D_TBil) is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for Atellica CH Diazo Total Bilirubin (D_TBil)?

The FDA product code for Atellica CH Diazo Total Bilirubin (D_TBil) is CIG.

Related Clinical Trials

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: CIG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.